Role of superoxide dismutase 3 in skin inflammation

Journal of Dermatological Science

Volumn 67, Issue 2, 2012, Pages 81-87

  Kwon, Myung Ja ^a   Kim, ByungHak ^a   Lee, Yun Sang ^a   Kim, Tae Yoon ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Extracellular; Heparin binding domain; Hyaluronic acid; Inflammation; RNS; ROS; Superoxide dismutase

Indexed keywords

CYTOKINE; EXTRACELLULAR SUPEROXIDE DISMUTASE; HYALURONIC ACID DERIVATIVE; HYALURONIC ACID FRAGMENT; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

CONTACT ALLERGY; ENZYME ACTIVITY; ENZYME STRUCTURE; EXTRACELLULAR MATRIX; IMMUNE RESPONSE; IMMUNOREGULATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; ULTRAVIOLET RADIATION;

ANIMALS; ANTIOXIDANTS; BINDING SITES; HEPARIN; HUMANS; HYALURONIC ACID; INFLAMMATION; MACROPHAGES; MICE; POLYSACCHARIDES; PROTEIN STRUCTURE, TERTIARY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SKIN; SUPEROXIDE DISMUTASE; T-LYMPHOCYTES;

EID: 84863863249     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.06.003     Document Type: Review

References (50)

1. Marklund S.L., Holme E., Hellner L. Superoxide dismutase in extracellular fluids. Clin Chim Acta 1982, 126:41-51.
2. Laurila J.P., Laatikainen L.E., Castellone M.D., Laukkanen M.O. SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression. PLoS ONE 2009, 4:e5786.
3. Marklund S.L. Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest 1984, 74:1398-1403.
4. Hendrickson D.J., Fisher J.H., Jones C., Ho Y.S. Regional localization of human extracellular superoxide dismutase gene to 4pter-q21. Genomics 1990, 8:736-738.
5. Gallagher D.S., Gibbs L.S., Shaffer J.B., Womack J.E. Somatic cell mapping of bovine EC-SOD and SOD1L loci. Genomics 1992, 12:610-612.
6. Zelko I.N., Mariani T.J., Folz R.J. Superoxide dismutase multigene family: a comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med 2002, 33:337-349.
7. Ho Y.S., Howard A.J., Crapo J.D. Molecular structure of a functional rat gene for manganese-containing superoxide dismutase. Am J Respir Cell Mol Biol 1991, 4:278-286.
8. Marklund S.L. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J 1984, 222:649-655.
9. Ookawara T., Imazeki N., Matsubara O., Kizaki T., Oh-Ishi S., Nakao C., et al. Tissue distribution of immunoreactive mouse extracellular superoxide dismutase. Am J Physiol 1998, 275:C840-C847.
10. Yao H., Arunachalam G., Hwang J.W., Chung S., Sundar I.K., Kinnula V.L., et al. Extracellular superoxide dismutase protects against pulmonary emphysema by attenuating oxidative fragmentation of ECM. Proc Natl Acad Sci USA 2010, 107:15571-15576.
11. Hjalmarsson K., Marklund S.L., Engstrom A., Edlund T. Isolation and sequence of complementary DNA encoding human extracellular superoxide dismutase. Proc Natl Acad Sci USA 1987, 84:6340-6344.
12. Edlund A., Edlund T., Hjalmarsson K., Marklund S.L., Sandstrom J., Stromqvist M., et al. A non-glycosylated extracellular superoxide dismutase variant. Biochem J 1992, 288(Pt 2):451-456.
13. Sandstrom J., Carlsson L., Marklund S.L., Edlund T. The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. J Biol Chem 1992, 267:18205-18209.
14. Oury T.D., Schaefer L.M., Fattman C.L., Choi A., Weck K.E., Watkins S.C. Depletion of pulmonary EC-SOD after exposure to hyperoxia. Am J Physiol Lung Cell Mol Physiol 2002, 283:L777-L784.
15. Ookawara T., Kizaki T., Takayama E., Imazeki N., Matsubara O., Ikeda Y., et al. Nuclear translocation of extracellular superoxide dismutase. Biochem Biophys Res Commun 2002, 296:54-61.
16. Moysan A., Marquis I., Gaboriau F., Santus R., Dubertret L., Morliere P. Ultraviolet A-induced lipid peroxidation and antioxidant defense systems in cultured human skin fibroblasts. J Invest Dermatol 1993, 100:692-698.
17. Poswig A., Wenk J., Brenneisen P., Wlaschek M., Hommel C., Quel G., et al. Adaptive antioxidant response of manganese-superoxide dismutase following repetitive UVA irradiation. J Invest Dermatol 1999, 112:13-18.
18. Ha H.Y., Kim Y., Ryoo Z.Y., Kim T.Y. Inhibition of the TPA-induced cutaneous inflammation and hyperplasia by EC-SOD. Biochem Biophys Res Commun 2006, 348:450-458.
19. Choung B.Y., Byun S.J., Suh J.G., Kim T.Y. Extracellular superoxide dismutase tissue distribution and the patterns of superoxide dismutase mRNA expression following ultraviolet irradiation on mouse skin. Exp Dermatol 2004, 13:691-699.
20. Yaar M., Gilchrest B.A. Photoageing: mechanism, prevention and therapy. Br J Dermatol 2007, 157:874-887.
21. Silberberg-Sinakin I., Thorbecke G.J. Contact hypersensitivity and Langerhans cells. J Invest Dermatol 1980, 75:61-67.
22. Gocinski B.L., Tigelaar R.E. Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990, 144:4121-4128.
23. Cavani A., Nasorri F., Prezzi C., Sebastiani S., Albanesi C., Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000, 114:295-302.
24. Toews G.B., Bergstresser P.R., Streilein J.W. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 1980, 124:445-453.
25. Fuchs J., Zollner T.M., Kaufmann R., Podda M. Redox-modulated pathways in inflammatory skin diseases. Free Radic Biol Med 2001, 30:337-353.
26. Nakamura Y., Murakami A., Ohto Y., Torikai K., Tanaka T., Ohigashi H. Suppression of tumor promoter-induced oxidative stress and inflammatory responses in mouse skin by a superoxide generation inhibitor 1'-acetoxychavicol acetate. Cancer Res 1998, 58:4832-4839.
27. Wang B., Zhuang L., Fujisawa H., Shinder G.A., Feliciani C., Shivji G.M., et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 1999, 162:277-283.
28. Marikovsky M., Ziv V., Nevo N., Harris-Cerruti C., Mahler O. Cu/Zn superoxide dismutase plays important role in immune response. J Immunol 2003, 170:2993-3001.
29. Lontz W., Sirsjo A., Liu W., Lindberg M., Rollman O., Torma H. Increased mRNA expression of manganese superoxide dismutase in psoriasis skin lesions and in cultured human keratinocytes exposed to IL-1 beta and TNF-alpha. Free Radic Biol Med 1995, 18:349-355.
30. Okayama Y. Oxidative stress in allergic and inflammatory skin diseases. Curr Drug Targets Inflamm Allergy 2005, 4:517-519.
31. Tsukahara H., Shibata R., Ohta N., Sato S., Hiraoka M., Ito S., et al. High levels of urinary pentosidine, an advanced glycation end product, in children with acute exacerbation of atopic dermatitis: relationship with oxidative stress. Metabolism 2003, 52:1601-1605.
32. Kim Y., Kim B.H., Lee H., Jeon B., Lee Y.S., Kwon M.J., et al. Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1alpha and NF-kappaB pathways. Free Radic Biol Med 2011, 51:1985-1995.
33. Chua R.A., Arbiser J.L. The role of angiogenesis in the pathogenesis of psoriasis. Autoimmunity 2009, 42:574-579.
34. Harrisson F. The extracellular matrix and cell surface, mediators of cell interactions in chicken gastrulation. Int J Dev Biol 1989, 33:417-438.
35. Raghow R. The role of extracellular matrix in postinflammatory wound healing and fibrosis. FASEB J 1994, 8:823-831.
36. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
37. Laurent T.C., Laurent U.B., Fraser J.R. Functions of hyaluronan. Ann Rheum Dis 1995, 54:429-432.
38. Pasonen-Seppanen S., Karvinen S., Torronen K., Hyttinen J.M., Jokela T., Lammi M.J., et al. EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. J Invest Dermatol 2003, 120:1038-1044.
39. Tammi R., Ripellino J.A., Margolis R.U., Maibach H.I., Tammi M. Hyaluronate accumulation in human epidermis treated with retinoic acid in skin organ culture. J Invest Dermatol 1989, 92:326-332.
40. John H.E., Price R.D. Perspectives in the selection of hyaluronic acid fillers for facial wrinkles and aging skin. Patient Prefer Adherence 2009, 3:225-230.
41. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001, 2:675-680.
42. Horton M.R., Burdick M.D., Strieter R.M., Bao C., Noble P.W. Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages. J Immunol 1998, 160:3023-3030.
43. McKee C.M., Penno M.B., Cowman M., Burdick M.D., Strieter R.M., Bao C., et al. Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest 1996, 98:2403-2413.
44. Gao F., Koenitzer J.R., Tobolewski J.M., Jiang D., Liang J., Noble P.W., et al. Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan. J Biol Chem 2008, 283:6058-6066.
45. Kwon M.J., Han J., Kim B.H., Lee Y.S., Kim T.Y. Superoxide dismutase 3 suppresses hyaluronic acid fragments mediated skin inflammation by inhibition of toll-like receptor 4 signaling pathway: superoxide dismutase 3 inhibits reactive oxygen species-induced trafficking of toll-like receptor 4 to lipid rafts. Antioxid Redox Signal 2011.
46. Wong S.W., Kwon M.J., Choi A.M., Kim H.P., Nakahira K., Hwang D.H. Fatty acids modulate toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J Biol Chem 2009, 284:27384-27392.
47. Hailman E., Lichenstein H.S., Wurfel M.M., Miller D.S., Johnson D.A., Kelley M., et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994, 179:269-277.
48. Pugin J., Schurer-Maly C.C., Leturcq D., Moriarty A., Ulevitch R.J., Tobias P.S. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993, 90:2744-2748.
49. Zhang H., Tay P.N., Cao W., Li W., Lu J. Integrin-nucleated toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling. FEBS Lett 2002, 532:171-176.
50. Peterson D.A., Archer S.L., Weir E.K. Superoxide reduction of a disulfide: a model of intracellular redox modulation?. Biochem Biophys Res Commun 1994, 200:1586-1591.